BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33417957)

  • 1. Hyperglycemic levels in early stage of diabetic nephropathy affect differentially renal expression of claudins-2 and -5 by oxidative stress.
    Rosas-Martínez L; Rodríguez-Muñoz R; Namorado-Tonix MDC; Missirlis F; Del Valle-Mondragón L; Sánchez-Mendoza A; Reyes-Sánchez JL; Cervantes-Pérez LG
    Life Sci; 2021 Mar; 268():119003. PubMed ID: 33417957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress induces claudin-2 nitration in experimental type 1 diabetic nephropathy.
    Molina-Jijón E; Rodríguez-Muñoz R; Namorado Mdel C; Pedraza-Chaverri J; Reyes JL
    Free Radic Biol Med; 2014 Jul; 72():162-75. PubMed ID: 24726862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone signaling regulates the over-expression of claudin-4 and -8 at the distal nephron from type 1 diabetic rats.
    Molina-Jijón E; Rodríguez-Muñoz R; González-Ramírez R; Namorado-Tónix C; Pedraza-Chaverri J; Reyes JL
    PLoS One; 2017; 12(5):e0177362. PubMed ID: 28493961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
    Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
    Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy.
    Kitada K; Nakano D; Ohsaki H; Hitomi H; Minamino T; Yatabe J; Felder RA; Mori H; Masaki T; Kobori H; Nishiyama A
    J Diabetes Complications; 2014; 28(5):604-11. PubMed ID: 24996978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats.
    Fernandes SM; Cordeiro PM; Watanabe M; Fonseca CD; Vattimo MF
    Arch Endocrinol Metab; 2016 Oct; 60(5):443-449. PubMed ID: 27812607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diphenyl diselenide ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats via suppressing oxidative stress and inflammation.
    Wang X; Li C; Huan Y; Cao H; Sun S; Lei L; Liu Q; Liu S; Ji W; Huang K; Shen Z; Zhou J
    Chem Biol Interact; 2021 Apr; 338():109427. PubMed ID: 33639173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats.
    Ni WJ; Ding HH; Zhou H; Qiu YY; Tang LQ
    Eur J Pharmacol; 2015 Oct; 764():448-456. PubMed ID: 26192633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc supplementation alleviates the progression of diabetic nephropathy by inhibiting the overexpression of oxidative-stress-mediated molecular markers in streptozotocin-induced experimental rats.
    Barman S; Pradeep SR; Srinivasan K
    J Nutr Biochem; 2018 Apr; 54():113-129. PubMed ID: 29331868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
    Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
    Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
    Shin SJ; Chung S; Kim SJ; Lee EM; Yoo YH; Kim JW; Ahn YB; Kim ES; Moon SD; Kim MJ; Ko SH
    PLoS One; 2016; 11(11):e0165703. PubMed ID: 27802313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney involvement in a nongenetic rat model of type 2 diabetes.
    Danda RS; Habiba NM; Rincon-Choles H; Bhandari BK; Barnes JL; Abboud HE; Pergola PE
    Kidney Int; 2005 Dec; 68(6):2562-71. PubMed ID: 16316331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
    Bishnoi HK; Mahadevan N; Balakumar P
    Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes.
    Al-Rasheed NM; Al-Rasheed NM; Bassiouni YA; Hasan IH; Al-Amin MA; Al-Ajmi HN; Mahmoud AM
    Biomed Pharmacother; 2018 Sep; 105():290-298. PubMed ID: 29860221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy.
    de Haan JB; Stefanovic N; Nikolic-Paterson D; Scurr LL; Croft KD; Mori TA; Hertzog P; Kola I; Atkins RC; Tesch GH
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F544-51. PubMed ID: 15827346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
    Zakaria EM; El-Maraghy NN; Ahmed AF; Ali AA; El-Bassossy HM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):621-631. PubMed ID: 28224182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kefir administration reduced progression of renal injury in STZ-diabetic rats by lowering oxidative stress.
    Punaro GR; Maciel FR; Rodrigues AM; Rogero MM; Bogsan CS; Oliveira MN; Ihara SS; Araujo SR; Sanches TR; Andrade LC; Higa EM
    Nitric Oxide; 2014 Feb; 37():53-60. PubMed ID: 24406684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in Streptozotocin-induced diabetic rats.
    Sun H; Ge N; Shao M; Cheng X; Li Y; Li S; Shen J
    Diabetes Res Clin Pract; 2013 Apr; 100(1):85-95. PubMed ID: 23384615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of renal tubule-specific knockdown of the Na
    Onishi A; Fu Y; Darshi M; Crespo-Masip M; Huang W; Song P; Patel R; Kim YC; Nespoux J; Freeman B; Soleimani M; Thomson S; Sharma K; Vallon V
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F419-F434. PubMed ID: 31166707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.